Therapy Optimization in Multiple Sclerosis (MS) (TOP MS)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Teva Neuroscience, Inc. )
ClinicalTrials.gov Identifier:
NCT00819000
First received: January 7, 2009
Last updated: January 28, 2013
Last verified: January 2013